Skip to main content
. Author manuscript; available in PMC: 2016 Jul 4.
Published in final edited form as: Kidney Int. 2016 Jan 4;89(1):68–81. doi: 10.1038/ki.2015.293

Figure 6. PP1 inhibits UUO injury –induced activation of Src in the kidney.

Figure 6

The left ureter was ligated for 7 days (a–c) with or without treatment of PP1 (2 mg/kg). The kidneys were taken for immunoblot analysis of phospho-Src (Tyr-416), Src, or α-tubulin as indicated (a). Representative immunoblots from 3 experiments are shown. Expression levels of phospho-Src and Src were quantified by densitometry and normalized with α-tubulin as indicated (b, c). Data are represented as the mean ± SEM (n=6). Bars with different letters (a–d) are significantly different from one another (P<0.05).